the United States began imposing additional tariffs on all goods imported from India for consumption or warehousing, raising the total tariff rate to 50%. This decision came after the US had already levied a 25% “reciprocal tariff” on Indian goods effective August 1, 2025. The latest 25% punitive tariff was imposed in response to India’s continued purchase of Russian oil. As the world’s second-largest pesticide market, the US had a pesticide market size of $10.7 billion (at ex-factory prices) in 2023, with imports accounting for $5.9 billion ($4.9 billion in active ingredients and $1 billion in formulated products). India, a major source of US pesticide imports, holds a 19% market share, valued at approximately $1.1 billion. The implementation of a 50% punitive tariff poses unprecedented challenges to India’s pesticide industry.
India’s Significant Role in the US Pesticide Market
India plays a crucial role in the US pesticide import market. Data from 2024 shows that China leads with a 42% share, exporting $2.5 billion worth of pesticides, followed by India with a 19% share. In comparison, traditional pesticide powerhouses such as the Netherlands and Germany hold 11% and 5% shares, respectively.
In terms of trade structure, active ingredients dominate India’s pesticide exports to the US, valued at $812 million and accounting for 72% of the total, while formulated products account for $315 million, or 28%. This export structure highlights India’s important position in the pesticide industry chain.
Notably, India’s pesticide exports exhibit a clear compared to China. China primarily exports high-volume, low-price generic pesticides such as glyphosate and glufosinate, most of which lost patent protection before 2005. In contrast, India’s export portfolio is more diversified.
Unique Advantages of India’s Pesticide Exports
A distinctive feature of India’s pesticide exports is that patented and proprietary molecules account for approximately 40% of its shipments, setting it apart from Chinese companies. Among India’s major exports to the US, pyroxasulfone leads with an export value of $167 million, though its patent is set to expire in 2026. Sulfoxaflor follows with an export value of $39.8 million, with its patent expiring in 2027. These patented molecules are primarily supplied by companies such as PI Industries and Deccan Fine Chemicals.
In the generic pesticide sector, Indian companies also perform strongly. Metribuzin exports are valued at $68.2 million, while bifenthrin and dicamba reach $67.2 million and $66 million, respectively. These generic products are dominated by companies such as UPL, Atul, and Rallis.
India’s competitive edge in the US market stems from several advantages. First, Indian companies have accumulated extensive experience in complex processes and the production of patented molecules, creating technical barriers to entry. Second, major companies have obtained international quality certifications, ensuring product reliability. Additionally, significant cost advantages over European and American producers, coupled with existing tariff protections against Chinese products, have further strengthened India’s position in the US market.
Direct Impact of the 50% Tariff
The imposition of a 50% tariff on Indian pesticides will deal a severe blow to Indian companies. From a pricing perspective, the average price of Indian pesticides in the US market is currently $23,400 per ton. After the tariff, this price will rise to $35,100 per ton. In comparison, the average price of Chinese products is only $12,400 per ton, putting Indian products at a significant competitive disadvantage. (Note: This data is approximate and not suitable for in-depth analysis.)
Different product categories will be affected to varying degrees. For patented molecules, substitutability is relatively limited in the short term due to technical barriers and patent protection. However, in the long run, multinational companies are likely to seek alternative suppliers. For generic products, which compete directly with Chinese products and are highly price-sensitive, a significant loss of market share is expected.
Based on trade elasticity analysis, the 50% tariff is projected to reduce India’s pesticide exports to the US by 40–60%. In terms of volume, exports are expected to drop by 45–65%, from 47,000 tons to 16,000–26,000 tons. Exports of patented pesticides are likely to decline by 20–30%, while generic pesticide exports could plummet by 60–80%.
Challenges for Key Enterprises
Leading Indian pesticide companies will face varying degrees of impact from the tariff. PI Industries, which focuses on patented molecules, derives 25–30% of its revenue from the US market. Key products such as pyroxasulfone will be directly affected. UPL Limited, which primarily produces generic pesticides, faces even greater challenges, as the US market accounts for about 20% of its global revenue. Aarti Industries, a major supplier of intermediates, will also be indirectly affected, despite not directly exporting finished products to the US. Companies like Rallis India, which focus on formulated products, are expected to see a 40–50% decline in US market revenue.
Opportunities Amid the Crisis
While the 50% tariff will significantly impact India’s pesticide industry, it also presents opportunities for development. First, external pressure may accelerate technological upgrades and push companies to move up the value chain. Second, forced market diversification could lead to a more balanced and stable global. Finally, a reassessment of the industry chain’s value may help companies strike a better balance between specialization and integration. In this process, India may move closer to China, either actively or passively, potentially transforming the “Dragon-Elephant rivalry” into “Dragon-Elephant cooperation.”
